On May 11, 2017, CFDA released three announcements as follows on seeking public comment on encouraging drug medical device innovation related policy:

Announcement of CFDA on Seeking Public Comments on Relevant Policies on Accelerating Evaluation and Approval for the Marketing Authorization of New Drugs and Medical Devices to Encourage Innovation in Drugs and Medical Devices (Draft for Public Comment) (2017 No. 52)

Announcement of CFDA on Seeking Public Comments regarding Relevant Policies on Implementing Drug and Medical Device Lifecycle Management to Encourage Innovation in Drugs and Medical Devices (Draft for Public Comment) (2017 No. 54)

Announcement of CFDA on Seeking Public Comments regarding Relevant Policies on Reforming the Administration of Clinical Trials to Encourage Innovation in Drugs and Medical Devices (Draft for Public Comment) (2017 No. 53)